Renal Denervation in the Real World: Practical Guidance for New Users

19

Apr

2022

16:00

BST

17:00

CEST

11:00

EST

Webinar

  • Views:

    Views Icon 6547
  • Likes:

    Heart Icon 24

Overview

During this unique broadcast, Radcliffe Medical Education brings together a globally-renowned European and American faculty to share best practices on resistant hypertension and renal denervation (RDN). If you manage patients with resistant hypertension – whether you treat directly or regularly refer patients to hypertension specialist services – this expert guidance will distil the most important practical points on identifying candidates for RDN. The aims of this broadcast are to draw attention to the current scale of resistant hypertension in the hypertensive population and to impart a sound understanding on appropriate patient selection for RDN.

Prof Roland Schmieder (University Hospital Erlangen, DE) leads proceedings, and is joined by Prof Michel Burnier (University Hospital of Lausanne, CH), Prof Cara East (Texas A&M College of Medicine, US) and Prof Konstantinos Tsioufis (University of Athens, GR) for a series of insightful presentations, discussions and live Q&A.

This broadcast is supported by an unrestricted educational grant from Medtronic.

Performed By:

Roland E Schmieder

Roland E Schmieder

Michel Burnier

Michel Burnier

Cara East

Cara East

Konstantinos Tsioufis

Konstantinos Tsioufis

Agenda

Introduction – Roland Schmieder

What Is the Place of RDN Today? – Konstantinos Tsioufis

- Which populations may derive benefit from RDN?
- Summary of trial data to date that support this

Summary of Best Practices: Captured From the Working Group – Cara East

- Aims of the working group
- Agreed set of principles
- Areas of potential differences between US and Europe

What Can Be Expected on RDN in the Future? – Michel Burnier

- Future position statements (ESH/AHA) and guidelines
- Future studies
- Working group publication

Discussion / live Q&A – All, moderated Roland Schmieder

Close – Roland Schmieder

Learning Objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials

Audience

  • Interventionalists
  • Nephrologists
  • Specialists engaged in treating hypertension
  • General Practitioners
  • General Cardiologists

Faculty Biographies

Roland E Schmieder

Roland E Schmieder

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Professor Schmieder is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the University of Tübingen, Germany.

View full profile
Michel Burnier

Michel Burnier

Michel Burnier is a Professor of Medicine and Head of the Division of Nephrology and Hypertension Consultation at the University Hospital of Lausanne in Switzerland. He is a member of several Swiss and international societies in the field of nephrology and hypertension. He is a member of the Scientific Council of the European Society of Hypertension (ESH) and a committee member of the Swiss Society of Hypertension. Professor Burnier is President Elect of the Swiss Society of Nephrology, President of the ethical review board of the University of Lausanne and a Board Member of Swissmedic, the Swiss Agency for Therapeutic Products. He is on the Editorial Board of several journals, including Hypertension and Blood Pressure. Professor Burnier trained in internal medicine and nephrology in Lausanne and at the University of Colorado Health Science Centre.

View full profile
Cara East

Cara East

Cara East is Clinical Professor of Medicine at Texas A&M College of Medicine, US. She is Board Certified in Internal Medicine, Cardiovascular Disease and Echocardiography.

Prof East has practiced general cardiology for over 30 years, with specific focus on prevention. At Texas Heart Center, Prof East leads a clinical research team, whose focus spans renal artery nerve ablation, anti-inflammatory drugs for the prevention of recurrent events after a heart attack, and drugs to lower cholesterol levels, among other areas. 

Prof East has lectured internationally, and is widely published in leading international journals.

View full profile
Konstantinos Tsioufis

Konstantinos Tsioufis

Konstantinos Tsioufis is Professor of Cardiology and Director of 1st Cardiological Department, National and Kapodistrian University of Athens, Hippokration Hospital, Greece. Prof Tsioufis works as an interventional Cardiologist as well as Hypertension Specialist and he was a post-doctoral fellow at the Veterans Affairs Medical Centre, Georgetown University Washington DC, US. Professor Tsioufis’s research focuses on the hypertensive disease, atherosclerotic cardiovascular disease and interventional cardiology. 

View full profile